Turn Therapeutics Inc (TTRX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$9.80-2.68%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TTRX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Operating Expenses & Income | ||||
| R&D Expenses | 0.8 | 0.3 | 0.2 | — |
| Operating Income | (7.0) | (5.9) | (1.8) | — |
| Earnings from Continuing Operations | ||||
| Interest & Investment Income | — | 0.0 | 0.0 | — |
| Other Non-Operating Income / Expenses | (1.5) | 2.7 | 0.0 | — |
| Net Income | ||||
| Net Income | (8.4) | (3.2) | (1.8) | — |
| Per Share | ||||
| Basic EPS | (0.28) | (0.12) | (0.07) | — |
| Diluted EPS | (0.28) | (0.12) | (0.07) | — |
| Basic Weighted Avg Shares | 29.8 | 27.7 | 26.6 | — |
| Diluted Weighted Avg Shares | 29.8 | 27.7 | 26.6 | — |
| Supplemental | ||||
| EBITDA | — | (5.8) | (1.7) | — |
| EBIT | (7.0) | (5.9) | (1.8) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.